IBC's 6th Annual Conference on Angiogenesis: Novel Therapeutic Developments.
Mousa
S A
SA
Dupont Pharmaceuticals Co., Wilmington, DE 19880-0400, USA. Shaker.A.Mousa.2@dupontpharma.com
D020533:Angiogenesis Inhibitors / Q000627:therapeutic use*; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D000925:Anticoagulants / Q000627:therapeutic use; D006801:Humans; D009389:Neovascularization, Pathologic / Q000188:drug therapy*
D020533:Angiogenesis Inhibitors; D000911:Antibodies, Monoclonal; D000925:Anticoagulants